Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Grande

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Blood|April 13, 2011
Long-term prognostic significance of response in multiple myeloma after stem cell transplantationJoaquin Martinez-Lopez, Joan Blade, María-Victoria Mateos, et al.
Bone Marrow Transplantation|January 25, 2018
Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registryAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematological Oncology|August 22, 2018
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatmentAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Leukemia|January 3, 2023
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, et al.
Blood|June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapySantiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
International Journal of Hematology|May 13, 2022
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practiceJuan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, et al.
Cancer Medicine|September 24, 2021
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world studyMaria Stefania Infante, Ana Fernández-Cruz, Lucia Núñez, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|April 13, 2011
Long-term prognostic significance of response in multiple myeloma after stem cell transplantationJoaquin Martinez-Lopez, Joan Blade, María-Victoria Mateos, et al.
Bone Marrow Transplantation|January 25, 2018
Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registryAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematological Oncology|August 22, 2018
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatmentAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Leukemia|January 3, 2023
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, et al.
Blood|June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapySantiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
International Journal of Hematology|May 13, 2022
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practiceJuan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, et al.
Cancer Medicine|September 24, 2021
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world studyMaria Stefania Infante, Ana Fernández-Cruz, Lucia Núñez, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 10